Global Odevixibat Market Growth 2026-2032
The global Odevixibat market size is predicted to grow from US$ 176 million in 2025 to US$ 427 million in 2032; it is expected to grow at a CAGR of 9.0% from 2026 to 2032.
In 2025, global odevixibat production reached approximately 120,000 units..Odevixibat is an orally administered small-molecule ileal bile acid transport (IBAT) inhibitor used for the treatment of rare cholestatic liver diseases. The drug works by selectively inhibiting the reabsorption of bile acids in the ileum, thereby reducing the accumulation of bile acids in the liver and bloodstream, decreasing intrahepatic cholestasis, alleviating symptoms such as pruritus, and improving liver function parameters. Odevixibat is primarily indicated for diseases such as progressive familial intrahepatic cholestasis (PFIC) and is an important targeted therapy in the field of rare diseases. It has been approved in multiple countries and regions for the treatment of pediatric patients and individuals with rare cholestatic liver disorders.
Odevixibat (brand name Bylvay), as the first oral IBAT inhibitor, is primarily used for the treatment of rare cholestatic liver diseases such as progressive familial intrahepatic cholestasis (PFIC), and is positioned within the rapidly growing rare disease therapeutics market. In recent years, driven by improved diagnosis rates of rare liver diseases, expansion of pediatric indications, and increasing demand for targeted therapies, this class of innovative drugs has demonstrated strong growth potential. Odevixibat has gradually achieved commercial penetration in Europe, the United States, and certain emerging markets, owing to its non-systemic mechanism of action and favorable efficacy in relieving pruritus symptoms. However, due to the extremely small patient population, the overall market size remains limited, and it also faces competition from other IBAT inhibitors and alternative treatments for cholestasis. Therefore, its future market growth will largely depend on indication expansion (such as ALGS), broader market access, and accumulation of long-term clinical data.
LP Information, Inc. (LPI) ' newest research report, the ?Odevixibat Industry Forecast? looks at past sales and reviews total world Odevixibat sales in 2025, providing a comprehensive analysis by region and market sector of projected Odevixibat sales for 2026 through 2032. With Odevixibat sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Odevixibat industry.
This Insight Report provides a comprehensive analysis of the global Odevixibat landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Odevixibat portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Odevixibat market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Odevixibat and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Odevixibat.
This report presents a comprehensive overview, market shares, and growth opportunities of Odevixibat market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Odevixibat market?
What factors are driving Odevixibat market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Odevixibat market opportunities vary by end market size?
How does Odevixibat break out by Type, by Application?
In 2025, global odevixibat production reached approximately 120,000 units..Odevixibat is an orally administered small-molecule ileal bile acid transport (IBAT) inhibitor used for the treatment of rare cholestatic liver diseases. The drug works by selectively inhibiting the reabsorption of bile acids in the ileum, thereby reducing the accumulation of bile acids in the liver and bloodstream, decreasing intrahepatic cholestasis, alleviating symptoms such as pruritus, and improving liver function parameters. Odevixibat is primarily indicated for diseases such as progressive familial intrahepatic cholestasis (PFIC) and is an important targeted therapy in the field of rare diseases. It has been approved in multiple countries and regions for the treatment of pediatric patients and individuals with rare cholestatic liver disorders.
Odevixibat (brand name Bylvay), as the first oral IBAT inhibitor, is primarily used for the treatment of rare cholestatic liver diseases such as progressive familial intrahepatic cholestasis (PFIC), and is positioned within the rapidly growing rare disease therapeutics market. In recent years, driven by improved diagnosis rates of rare liver diseases, expansion of pediatric indications, and increasing demand for targeted therapies, this class of innovative drugs has demonstrated strong growth potential. Odevixibat has gradually achieved commercial penetration in Europe, the United States, and certain emerging markets, owing to its non-systemic mechanism of action and favorable efficacy in relieving pruritus symptoms. However, due to the extremely small patient population, the overall market size remains limited, and it also faces competition from other IBAT inhibitors and alternative treatments for cholestasis. Therefore, its future market growth will largely depend on indication expansion (such as ALGS), broader market access, and accumulation of long-term clinical data.
LP Information, Inc. (LPI) ' newest research report, the ?Odevixibat Industry Forecast? looks at past sales and reviews total world Odevixibat sales in 2025, providing a comprehensive analysis by region and market sector of projected Odevixibat sales for 2026 through 2032. With Odevixibat sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Odevixibat industry.
This Insight Report provides a comprehensive analysis of the global Odevixibat landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Odevixibat portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Odevixibat market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Odevixibat and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Odevixibat.
This report presents a comprehensive overview, market shares, and growth opportunities of Odevixibat market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- 1.2 mg capsules
- 0.6 mg capsules
- 200 mcg Granules
- 600 mcg Granules
- Combination of Odevixibat and Bile Acid Sequestrants
- Combination of Odevixibat and Hepatoprotective Agents
- Hospital
- Retail
- Online
- Originator
- Generic
- Progressive Familial Intrahepatic Cholestasis (PFIC)
- Alagille Syndrome (ALGS)
- Cholestatic Pruritus in Children and Adults
- Biliary Atresia & Other Rare Cholestatic Liver Diseases%li%%li%??????Biliary Atresia????? ??????Odevixibat?????????? ??????Odevixibat??????????
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Ipsen Pharma
- Albireo Pharma
What is the 10-year outlook for the global Odevixibat market?
What factors are driving Odevixibat market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Odevixibat market opportunities vary by end market size?
How does Odevixibat break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Odevixibat Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Odevixibat by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Odevixibat by Country/Region, 2021, 2025 & 2032
2.2 Odevixibat Segment by Type
2.2.1 1.2 mg capsules
2.2.2 0.6 mg capsules
2.2.3 200 mcg Granules
2.2.4 600 mcg Granules
2.2.5 Odevixibat Sales by Type
2.2.5.1 Global Odevixibat Sales Market Share by Type (2021-2026)
2.2.5.2 Global Odevixibat Revenue and Market Share by Type (2021-2026)
2.2.5.3 Global Odevixibat Sale Price by Type (2021-2026)
2.3 Odevixibat Segment by Combination Therapy
2.3.1 Combination of Odevixibat and Bile Acid Sequestrants
2.3.2 Combination of Odevixibat and Hepatoprotective Agents
2.3.3 Odevixibat Sales by Combination Therapy
2.3.3.1 Global Odevixibat Sales Market Share by Combination Therapy (2021-2026)
2.3.3.2 Global Odevixibat Revenue and Market Share by Combination Therapy (2021-2026)
2.3.3.3 Global Odevixibat Sale Price by Combination Therapy (2021-2026)
2.4 Odevixibat Segment by Sales Channels
2.4.1 Hospital
2.4.2 Retail
2.4.3 Online
2.4.4 Odevixibat Sales by Sales Channels
2.4.4.1 Global Odevixibat Sales Market Share by Sales Channels (2021-2026)
2.4.4.2 Global Odevixibat Revenue and Market Share by Sales Channels (2021-2026)
2.4.4.3 Global Odevixibat Sale Price by Sales Channels (2021-2026)
2.5 Odevixibat Segment by Production Technology
2.5.1 Originator
2.5.2 Generic
2.5.3 Odevixibat Sales by Production Technology
2.5.3.1 Global Odevixibat Sales Market Share by Production Technology (2021-2026)
2.5.3.2 Global Odevixibat Revenue and Market Share by Production Technology (2021-2026)
2.5.3.3 Global Odevixibat Sale Price by Production Technology (2021-2026)
2.6 Odevixibat Segment by Application
2.6.1 Progressive Familial Intrahepatic Cholestasis (PFIC)
2.6.2 Alagille Syndrome (ALGS)
2.6.3 Cholestatic Pruritus in Children and Adults
2.6.4 Biliary Atresia & Other Rare Cholestatic Liver Diseases ??????Biliary Atresia????? ??????Odevixibat?????????? ??????Odevixibat??????????
2.6.5 Others
2.6.6 Odevixibat Sales by Application
2.6.6.1 Global Odevixibat Sale Market Share by Application (2021-2026)
2.6.6.2 Global Odevixibat Revenue and Market Share by Application (2021-2026)
2.6.6.3 Global Odevixibat Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Odevixibat Breakdown Data by Company
3.1.1 Global Odevixibat Annual Sales by Company (2021-2026)
3.1.2 Global Odevixibat Sales Market Share by Company (2021-2026)
3.2 Global Odevixibat Annual Revenue by Company (2021-2026)
3.2.1 Global Odevixibat Revenue by Company (2021-2026)
3.2.2 Global Odevixibat Revenue Market Share by Company (2021-2026)
3.3 Global Odevixibat Sale Price by Company
3.4 Key Manufacturers Odevixibat Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Odevixibat Product Location Distribution
3.4.2 Players Odevixibat Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ODEVIXIBAT BY GEOGRAPHIC REGION
4.1 World Historic Odevixibat Market Size by Geographic Region (2021-2026)
4.1.1 Global Odevixibat Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Odevixibat Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Odevixibat Market Size by Country/Region (2021-2026)
4.2.1 Global Odevixibat Annual Sales by Country/Region (2021-2026)
4.2.2 Global Odevixibat Annual Revenue by Country/Region (2021-2026)
4.3 Americas Odevixibat Sales Growth
4.4 APAC Odevixibat Sales Growth
4.5 Europe Odevixibat Sales Growth
4.6 Middle East & Africa Odevixibat Sales Growth
5 AMERICAS
5.1 Americas Odevixibat Sales by Country
5.1.1 Americas Odevixibat Sales by Country (2021-2026)
5.1.2 Americas Odevixibat Revenue by Country (2021-2026)
5.2 Americas Odevixibat Sales by Type (2021-2026)
5.3 Americas Odevixibat Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Odevixibat Sales by Region
6.1.1 APAC Odevixibat Sales by Region (2021-2026)
6.1.2 APAC Odevixibat Revenue by Region (2021-2026)
6.2 APAC Odevixibat Sales by Type (2021-2026)
6.3 APAC Odevixibat Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Odevixibat by Country
7.1.1 Europe Odevixibat Sales by Country (2021-2026)
7.1.2 Europe Odevixibat Revenue by Country (2021-2026)
7.2 Europe Odevixibat Sales by Type (2021-2026)
7.3 Europe Odevixibat Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Odevixibat by Country
8.1.1 Middle East & Africa Odevixibat Sales by Country (2021-2026)
8.1.2 Middle East & Africa Odevixibat Revenue by Country (2021-2026)
8.2 Middle East & Africa Odevixibat Sales by Type (2021-2026)
8.3 Middle East & Africa Odevixibat Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Odevixibat
10.3 Manufacturing Process Analysis of Odevixibat
10.4 Industry Chain Structure of Odevixibat
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Odevixibat Distributors
11.3 Odevixibat Customer
12 WORLD FORECAST REVIEW FOR ODEVIXIBAT BY GEOGRAPHIC REGION
12.1 Global Odevixibat Market Size Forecast by Region
12.1.1 Global Odevixibat Forecast by Region (2027-2032)
12.1.2 Global Odevixibat Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Odevixibat Forecast by Type (2027-2032)
12.7 Global Odevixibat Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Ipsen Pharma
13.1.1 Ipsen Pharma Company Information
13.1.2 Ipsen Pharma Odevixibat Product Portfolios and Specifications
13.1.3 Ipsen Pharma Odevixibat Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Ipsen Pharma Main Business Overview
13.1.5 Ipsen Pharma Latest Developments
13.2 Albireo Pharma
13.2.1 Albireo Pharma Company Information
13.2.2 Albireo Pharma Odevixibat Product Portfolios and Specifications
13.2.3 Albireo Pharma Odevixibat Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Albireo Pharma Main Business Overview
13.2.5 Albireo Pharma Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Odevixibat Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Odevixibat by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Odevixibat by Country/Region, 2021, 2025 & 2032
2.2 Odevixibat Segment by Type
2.2.1 1.2 mg capsules
2.2.2 0.6 mg capsules
2.2.3 200 mcg Granules
2.2.4 600 mcg Granules
2.2.5 Odevixibat Sales by Type
2.2.5.1 Global Odevixibat Sales Market Share by Type (2021-2026)
2.2.5.2 Global Odevixibat Revenue and Market Share by Type (2021-2026)
2.2.5.3 Global Odevixibat Sale Price by Type (2021-2026)
2.3 Odevixibat Segment by Combination Therapy
2.3.1 Combination of Odevixibat and Bile Acid Sequestrants
2.3.2 Combination of Odevixibat and Hepatoprotective Agents
2.3.3 Odevixibat Sales by Combination Therapy
2.3.3.1 Global Odevixibat Sales Market Share by Combination Therapy (2021-2026)
2.3.3.2 Global Odevixibat Revenue and Market Share by Combination Therapy (2021-2026)
2.3.3.3 Global Odevixibat Sale Price by Combination Therapy (2021-2026)
2.4 Odevixibat Segment by Sales Channels
2.4.1 Hospital
2.4.2 Retail
2.4.3 Online
2.4.4 Odevixibat Sales by Sales Channels
2.4.4.1 Global Odevixibat Sales Market Share by Sales Channels (2021-2026)
2.4.4.2 Global Odevixibat Revenue and Market Share by Sales Channels (2021-2026)
2.4.4.3 Global Odevixibat Sale Price by Sales Channels (2021-2026)
2.5 Odevixibat Segment by Production Technology
2.5.1 Originator
2.5.2 Generic
2.5.3 Odevixibat Sales by Production Technology
2.5.3.1 Global Odevixibat Sales Market Share by Production Technology (2021-2026)
2.5.3.2 Global Odevixibat Revenue and Market Share by Production Technology (2021-2026)
2.5.3.3 Global Odevixibat Sale Price by Production Technology (2021-2026)
2.6 Odevixibat Segment by Application
2.6.1 Progressive Familial Intrahepatic Cholestasis (PFIC)
2.6.2 Alagille Syndrome (ALGS)
2.6.3 Cholestatic Pruritus in Children and Adults
2.6.4 Biliary Atresia & Other Rare Cholestatic Liver Diseases ??????Biliary Atresia????? ??????Odevixibat?????????? ??????Odevixibat??????????
2.6.5 Others
2.6.6 Odevixibat Sales by Application
2.6.6.1 Global Odevixibat Sale Market Share by Application (2021-2026)
2.6.6.2 Global Odevixibat Revenue and Market Share by Application (2021-2026)
2.6.6.3 Global Odevixibat Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Odevixibat Breakdown Data by Company
3.1.1 Global Odevixibat Annual Sales by Company (2021-2026)
3.1.2 Global Odevixibat Sales Market Share by Company (2021-2026)
3.2 Global Odevixibat Annual Revenue by Company (2021-2026)
3.2.1 Global Odevixibat Revenue by Company (2021-2026)
3.2.2 Global Odevixibat Revenue Market Share by Company (2021-2026)
3.3 Global Odevixibat Sale Price by Company
3.4 Key Manufacturers Odevixibat Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Odevixibat Product Location Distribution
3.4.2 Players Odevixibat Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ODEVIXIBAT BY GEOGRAPHIC REGION
4.1 World Historic Odevixibat Market Size by Geographic Region (2021-2026)
4.1.1 Global Odevixibat Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Odevixibat Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Odevixibat Market Size by Country/Region (2021-2026)
4.2.1 Global Odevixibat Annual Sales by Country/Region (2021-2026)
4.2.2 Global Odevixibat Annual Revenue by Country/Region (2021-2026)
4.3 Americas Odevixibat Sales Growth
4.4 APAC Odevixibat Sales Growth
4.5 Europe Odevixibat Sales Growth
4.6 Middle East & Africa Odevixibat Sales Growth
5 AMERICAS
5.1 Americas Odevixibat Sales by Country
5.1.1 Americas Odevixibat Sales by Country (2021-2026)
5.1.2 Americas Odevixibat Revenue by Country (2021-2026)
5.2 Americas Odevixibat Sales by Type (2021-2026)
5.3 Americas Odevixibat Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Odevixibat Sales by Region
6.1.1 APAC Odevixibat Sales by Region (2021-2026)
6.1.2 APAC Odevixibat Revenue by Region (2021-2026)
6.2 APAC Odevixibat Sales by Type (2021-2026)
6.3 APAC Odevixibat Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Odevixibat by Country
7.1.1 Europe Odevixibat Sales by Country (2021-2026)
7.1.2 Europe Odevixibat Revenue by Country (2021-2026)
7.2 Europe Odevixibat Sales by Type (2021-2026)
7.3 Europe Odevixibat Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Odevixibat by Country
8.1.1 Middle East & Africa Odevixibat Sales by Country (2021-2026)
8.1.2 Middle East & Africa Odevixibat Revenue by Country (2021-2026)
8.2 Middle East & Africa Odevixibat Sales by Type (2021-2026)
8.3 Middle East & Africa Odevixibat Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Odevixibat
10.3 Manufacturing Process Analysis of Odevixibat
10.4 Industry Chain Structure of Odevixibat
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Odevixibat Distributors
11.3 Odevixibat Customer
12 WORLD FORECAST REVIEW FOR ODEVIXIBAT BY GEOGRAPHIC REGION
12.1 Global Odevixibat Market Size Forecast by Region
12.1.1 Global Odevixibat Forecast by Region (2027-2032)
12.1.2 Global Odevixibat Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Odevixibat Forecast by Type (2027-2032)
12.7 Global Odevixibat Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Ipsen Pharma
13.1.1 Ipsen Pharma Company Information
13.1.2 Ipsen Pharma Odevixibat Product Portfolios and Specifications
13.1.3 Ipsen Pharma Odevixibat Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Ipsen Pharma Main Business Overview
13.1.5 Ipsen Pharma Latest Developments
13.2 Albireo Pharma
13.2.1 Albireo Pharma Company Information
13.2.2 Albireo Pharma Odevixibat Product Portfolios and Specifications
13.2.3 Albireo Pharma Odevixibat Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Albireo Pharma Main Business Overview
13.2.5 Albireo Pharma Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Odevixibat Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Odevixibat Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 1.2 mg capsules
Table 4. Major Players of 0.6 mg capsules
Table 5. Major Players of 200 mcg Granules
Table 6. Major Players of 600 mcg Granules
Table 7. Global Odevixibat Sales by Type (2021-2026) & (Units)
Table 8. Global Odevixibat Sales Market Share by Type (2021-2026)
Table 9. Global Odevixibat Revenue by Type (2021-2026) & ($ million)
Table 10. Global Odevixibat Revenue Market Share by Type (2021-2026)
Table 11. Global Odevixibat Sale Price by Type (2021-2026) & (US$/Unit)
Table 12. Major Players of Combination of Odevixibat and Bile Acid Sequestrants
Table 13. Major Players of Combination of Odevixibat and Hepatoprotective Agents
Table 14. Global Odevixibat Sales by Combination Therapy (2021-2026) & (Units)
Table 15. Global Odevixibat Sales Market Share by Combination Therapy (2021-2026)
Table 16. Global Odevixibat Revenue by Combination Therapy (2021-2026) & ($ million)
Table 17. Global Odevixibat Revenue Market Share by Combination Therapy (2021-2026)
Table 18. Global Odevixibat Sale Price by Combination Therapy (2021-2026) & (US$/Unit)
Table 19. Major Players of Hospital
Table 20. Major Players of Retail
Table 21. Major Players of Online
Table 22. Global Odevixibat Sales by Sales Channels (2021-2026) & (Units)
Table 23. Global Odevixibat Sales Market Share by Sales Channels (2021-2026)
Table 24. Global Odevixibat Revenue by Sales Channels (2021-2026) & ($ million)
Table 25. Global Odevixibat Revenue Market Share by Sales Channels (2021-2026)
Table 26. Global Odevixibat Sale Price by Sales Channels (2021-2026) & (US$/Unit)
Table 27. Major Players of Originator
Table 28. Major Players of Generic
Table 29. Global Odevixibat Sales by Production Technology (2021-2026) & (Units)
Table 30. Global Odevixibat Sales Market Share by Production Technology (2021-2026)
Table 31. Global Odevixibat Revenue by Production Technology (2021-2026) & ($ million)
Table 32. Global Odevixibat Revenue Market Share by Production Technology (2021-2026)
Table 33. Global Odevixibat Sale Price by Production Technology (2021-2026) & (US$/Unit)
Table 34. Global Odevixibat Sale by Application (2021-2026) & (Units)
Table 35. Global Odevixibat Sale Market Share by Application (2021-2026)
Table 36. Global Odevixibat Revenue by Application (2021-2026) & ($ million)
Table 37. Global Odevixibat Revenue Market Share by Application (2021-2026)
Table 38. Global Odevixibat Sale Price by Application (2021-2026) & (US$/Unit)
Table 39. Global Odevixibat Sales by Company (2021-2026) & (Units)
Table 40. Global Odevixibat Sales Market Share by Company (2021-2026)
Table 41. Global Odevixibat Revenue by Company (2021-2026) & ($ millions)
Table 42. Global Odevixibat Revenue Market Share by Company (2021-2026)
Table 43. Global Odevixibat Sale Price by Company (2021-2026) & (US$/Unit)
Table 44. Key Manufacturers Odevixibat Producing Area Distribution and Sales Area
Table 45. Players Odevixibat Products Offered
Table 46. Odevixibat Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 47. New Products and Potential Entrants
Table 48. Market M&A Activity & Strategy
Table 49. Global Odevixibat Sales by Geographic Region (2021-2026) & (Units)
Table 50. Global Odevixibat Sales Market Share Geographic Region (2021-2026)
Table 51. Global Odevixibat Revenue by Geographic Region (2021-2026) & ($ millions)
Table 52. Global Odevixibat Revenue Market Share by Geographic Region (2021-2026)
Table 53. Global Odevixibat Sales by Country/Region (2021-2026) & (Units)
Table 54. Global Odevixibat Sales Market Share by Country/Region (2021-2026)
Table 55. Global Odevixibat Revenue by Country/Region (2021-2026) & ($ millions)
Table 56. Global Odevixibat Revenue Market Share by Country/Region (2021-2026)
Table 57. Americas Odevixibat Sales by Country (2021-2026) & (Units)
Table 58. Americas Odevixibat Sales Market Share by Country (2021-2026)
Table 59. Americas Odevixibat Revenue by Country (2021-2026) & ($ millions)
Table 60. Americas Odevixibat Sales by Type (2021-2026) & (Units)
Table 61. Americas Odevixibat Sales by Application (2021-2026) & (Units)
Table 62. APAC Odevixibat Sales by Region (2021-2026) & (Units)
Table 63. APAC Odevixibat Sales Market Share by Region (2021-2026)
Table 64. APAC Odevixibat Revenue by Region (2021-2026) & ($ millions)
Table 65. APAC Odevixibat Sales by Type (2021-2026) & (Units)
Table 66. APAC Odevixibat Sales by Application (2021-2026) & (Units)
Table 67. Europe Odevixibat Sales by Country (2021-2026) & (Units)
Table 68. Europe Odevixibat Revenue by Country (2021-2026) & ($ millions)
Table 69. Europe Odevixibat Sales by Type (2021-2026) & (Units)
Table 70. Europe Odevixibat Sales by Application (2021-2026) & (Units)
Table 71. Middle East & Africa Odevixibat Sales by Country (2021-2026) & (Units)
Table 72. Middle East & Africa Odevixibat Revenue Market Share by Country (2021-2026)
Table 73. Middle East & Africa Odevixibat Sales by Type (2021-2026) & (Units)
Table 74. Middle East & Africa Odevixibat Sales by Application (2021-2026) & (Units)
Table 75. Key Market Drivers & Growth Opportunities of Odevixibat
Table 76. Key Market Challenges & Risks of Odevixibat
Table 77. Key Industry Trends of Odevixibat
Table 78. Odevixibat Raw Material
Table 79. Key Suppliers of Raw Materials
Table 80. Odevixibat Distributors List
Table 81. Odevixibat Customer List
Table 82. Global Odevixibat Sales Forecast by Region (2027-2032) & (Units)
Table 83. Global Odevixibat Revenue Forecast by Region (2027-2032) & ($ millions)
Table 84. Americas Odevixibat Sales Forecast by Country (2027-2032) & (Units)
Table 85. Americas Odevixibat Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 86. APAC Odevixibat Sales Forecast by Region (2027-2032) & (Units)
Table 87. APAC Odevixibat Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 88. Europe Odevixibat Sales Forecast by Country (2027-2032) & (Units)
Table 89. Europe Odevixibat Revenue Forecast by Country (2027-2032) & ($ millions)
Table 90. Middle East & Africa Odevixibat Sales Forecast by Country (2027-2032) & (Units)
Table 91. Middle East & Africa Odevixibat Revenue Forecast by Country (2027-2032) & ($ millions)
Table 92. Global Odevixibat Sales Forecast by Type (2027-2032) & (Units)
Table 93. Global Odevixibat Revenue Forecast by Type (2027-2032) & ($ millions)
Table 94. Global Odevixibat Sales Forecast by Application (2027-2032) & (Units)
Table 95. Global Odevixibat Revenue Forecast by Application (2027-2032) & ($ millions)
Table 96. Ipsen Pharma Basic Information, Odevixibat Manufacturing Base, Sales Area and Its Competitors
Table 97. Ipsen Pharma Odevixibat Product Portfolios and Specifications
Table 98. Ipsen Pharma Odevixibat Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 99. Ipsen Pharma Main Business
Table 100. Ipsen Pharma Latest Developments
Table 101. Albireo Pharma Basic Information, Odevixibat Manufacturing Base, Sales Area and Its Competitors
Table 102. Albireo Pharma Odevixibat Product Portfolios and Specifications
Table 103. Albireo Pharma Odevixibat Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 104. Albireo Pharma Main Business
Table 105. Albireo Pharma Latest Developments
Table 1. Odevixibat Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Odevixibat Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 1.2 mg capsules
Table 4. Major Players of 0.6 mg capsules
Table 5. Major Players of 200 mcg Granules
Table 6. Major Players of 600 mcg Granules
Table 7. Global Odevixibat Sales by Type (2021-2026) & (Units)
Table 8. Global Odevixibat Sales Market Share by Type (2021-2026)
Table 9. Global Odevixibat Revenue by Type (2021-2026) & ($ million)
Table 10. Global Odevixibat Revenue Market Share by Type (2021-2026)
Table 11. Global Odevixibat Sale Price by Type (2021-2026) & (US$/Unit)
Table 12. Major Players of Combination of Odevixibat and Bile Acid Sequestrants
Table 13. Major Players of Combination of Odevixibat and Hepatoprotective Agents
Table 14. Global Odevixibat Sales by Combination Therapy (2021-2026) & (Units)
Table 15. Global Odevixibat Sales Market Share by Combination Therapy (2021-2026)
Table 16. Global Odevixibat Revenue by Combination Therapy (2021-2026) & ($ million)
Table 17. Global Odevixibat Revenue Market Share by Combination Therapy (2021-2026)
Table 18. Global Odevixibat Sale Price by Combination Therapy (2021-2026) & (US$/Unit)
Table 19. Major Players of Hospital
Table 20. Major Players of Retail
Table 21. Major Players of Online
Table 22. Global Odevixibat Sales by Sales Channels (2021-2026) & (Units)
Table 23. Global Odevixibat Sales Market Share by Sales Channels (2021-2026)
Table 24. Global Odevixibat Revenue by Sales Channels (2021-2026) & ($ million)
Table 25. Global Odevixibat Revenue Market Share by Sales Channels (2021-2026)
Table 26. Global Odevixibat Sale Price by Sales Channels (2021-2026) & (US$/Unit)
Table 27. Major Players of Originator
Table 28. Major Players of Generic
Table 29. Global Odevixibat Sales by Production Technology (2021-2026) & (Units)
Table 30. Global Odevixibat Sales Market Share by Production Technology (2021-2026)
Table 31. Global Odevixibat Revenue by Production Technology (2021-2026) & ($ million)
Table 32. Global Odevixibat Revenue Market Share by Production Technology (2021-2026)
Table 33. Global Odevixibat Sale Price by Production Technology (2021-2026) & (US$/Unit)
Table 34. Global Odevixibat Sale by Application (2021-2026) & (Units)
Table 35. Global Odevixibat Sale Market Share by Application (2021-2026)
Table 36. Global Odevixibat Revenue by Application (2021-2026) & ($ million)
Table 37. Global Odevixibat Revenue Market Share by Application (2021-2026)
Table 38. Global Odevixibat Sale Price by Application (2021-2026) & (US$/Unit)
Table 39. Global Odevixibat Sales by Company (2021-2026) & (Units)
Table 40. Global Odevixibat Sales Market Share by Company (2021-2026)
Table 41. Global Odevixibat Revenue by Company (2021-2026) & ($ millions)
Table 42. Global Odevixibat Revenue Market Share by Company (2021-2026)
Table 43. Global Odevixibat Sale Price by Company (2021-2026) & (US$/Unit)
Table 44. Key Manufacturers Odevixibat Producing Area Distribution and Sales Area
Table 45. Players Odevixibat Products Offered
Table 46. Odevixibat Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 47. New Products and Potential Entrants
Table 48. Market M&A Activity & Strategy
Table 49. Global Odevixibat Sales by Geographic Region (2021-2026) & (Units)
Table 50. Global Odevixibat Sales Market Share Geographic Region (2021-2026)
Table 51. Global Odevixibat Revenue by Geographic Region (2021-2026) & ($ millions)
Table 52. Global Odevixibat Revenue Market Share by Geographic Region (2021-2026)
Table 53. Global Odevixibat Sales by Country/Region (2021-2026) & (Units)
Table 54. Global Odevixibat Sales Market Share by Country/Region (2021-2026)
Table 55. Global Odevixibat Revenue by Country/Region (2021-2026) & ($ millions)
Table 56. Global Odevixibat Revenue Market Share by Country/Region (2021-2026)
Table 57. Americas Odevixibat Sales by Country (2021-2026) & (Units)
Table 58. Americas Odevixibat Sales Market Share by Country (2021-2026)
Table 59. Americas Odevixibat Revenue by Country (2021-2026) & ($ millions)
Table 60. Americas Odevixibat Sales by Type (2021-2026) & (Units)
Table 61. Americas Odevixibat Sales by Application (2021-2026) & (Units)
Table 62. APAC Odevixibat Sales by Region (2021-2026) & (Units)
Table 63. APAC Odevixibat Sales Market Share by Region (2021-2026)
Table 64. APAC Odevixibat Revenue by Region (2021-2026) & ($ millions)
Table 65. APAC Odevixibat Sales by Type (2021-2026) & (Units)
Table 66. APAC Odevixibat Sales by Application (2021-2026) & (Units)
Table 67. Europe Odevixibat Sales by Country (2021-2026) & (Units)
Table 68. Europe Odevixibat Revenue by Country (2021-2026) & ($ millions)
Table 69. Europe Odevixibat Sales by Type (2021-2026) & (Units)
Table 70. Europe Odevixibat Sales by Application (2021-2026) & (Units)
Table 71. Middle East & Africa Odevixibat Sales by Country (2021-2026) & (Units)
Table 72. Middle East & Africa Odevixibat Revenue Market Share by Country (2021-2026)
Table 73. Middle East & Africa Odevixibat Sales by Type (2021-2026) & (Units)
Table 74. Middle East & Africa Odevixibat Sales by Application (2021-2026) & (Units)
Table 75. Key Market Drivers & Growth Opportunities of Odevixibat
Table 76. Key Market Challenges & Risks of Odevixibat
Table 77. Key Industry Trends of Odevixibat
Table 78. Odevixibat Raw Material
Table 79. Key Suppliers of Raw Materials
Table 80. Odevixibat Distributors List
Table 81. Odevixibat Customer List
Table 82. Global Odevixibat Sales Forecast by Region (2027-2032) & (Units)
Table 83. Global Odevixibat Revenue Forecast by Region (2027-2032) & ($ millions)
Table 84. Americas Odevixibat Sales Forecast by Country (2027-2032) & (Units)
Table 85. Americas Odevixibat Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 86. APAC Odevixibat Sales Forecast by Region (2027-2032) & (Units)
Table 87. APAC Odevixibat Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 88. Europe Odevixibat Sales Forecast by Country (2027-2032) & (Units)
Table 89. Europe Odevixibat Revenue Forecast by Country (2027-2032) & ($ millions)
Table 90. Middle East & Africa Odevixibat Sales Forecast by Country (2027-2032) & (Units)
Table 91. Middle East & Africa Odevixibat Revenue Forecast by Country (2027-2032) & ($ millions)
Table 92. Global Odevixibat Sales Forecast by Type (2027-2032) & (Units)
Table 93. Global Odevixibat Revenue Forecast by Type (2027-2032) & ($ millions)
Table 94. Global Odevixibat Sales Forecast by Application (2027-2032) & (Units)
Table 95. Global Odevixibat Revenue Forecast by Application (2027-2032) & ($ millions)
Table 96. Ipsen Pharma Basic Information, Odevixibat Manufacturing Base, Sales Area and Its Competitors
Table 97. Ipsen Pharma Odevixibat Product Portfolios and Specifications
Table 98. Ipsen Pharma Odevixibat Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 99. Ipsen Pharma Main Business
Table 100. Ipsen Pharma Latest Developments
Table 101. Albireo Pharma Basic Information, Odevixibat Manufacturing Base, Sales Area and Its Competitors
Table 102. Albireo Pharma Odevixibat Product Portfolios and Specifications
Table 103. Albireo Pharma Odevixibat Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 104. Albireo Pharma Main Business
Table 105. Albireo Pharma Latest Developments
LIST OF FIGURES
Figure 1. Picture of Odevixibat
Figure 2. Odevixibat Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Odevixibat Sales Growth Rate 2021-2032 (Units)
Figure 7. Global Odevixibat Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Odevixibat Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Odevixibat Sales Market Share by Country/Region (2025)
Figure 10. Odevixibat Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 1.2 mg capsules
Figure 12. Product Picture of 0.6 mg capsules
Figure 13. Product Picture of 200 mcg Granules
Figure 14. Product Picture of 600 mcg Granules
Figure 15. Global Odevixibat Sales Market Share by Type in 2026
Figure 16. Global Odevixibat Revenue Market Share by Type (2021-2026)
Figure 17. Product Picture of Combination of Odevixibat and Bile Acid Sequestrants
Figure 18. Product Picture of Combination of Odevixibat and Hepatoprotective Agents
Figure 19. Global Odevixibat Sales Market Share by Combination Therapy in 2026
Figure 20. Global Odevixibat Revenue Market Share by Combination Therapy (2021-2026)
Figure 21. Product Picture of Hospital
Figure 22. Product Picture of Retail
Figure 23. Product Picture of Online
Figure 24. Global Odevixibat Sales Market Share by Sales Channels in 2026
Figure 25. Global Odevixibat Revenue Market Share by Sales Channels (2021-2026)
Figure 26. Product Picture of Originator
Figure 27. Product Picture of Generic
Figure 28. Global Odevixibat Sales Market Share by Production Technology in 2026
Figure 29. Global Odevixibat Revenue Market Share by Production Technology (2021-2026)
Figure 30. Odevixibat Consumed in Progressive Familial Intrahepatic Cholestasis (PFIC)
Figure 31. Global Odevixibat Market: Progressive Familial Intrahepatic Cholestasis (PFIC) (2021-2026) & (Units)
Figure 32. Odevixibat Consumed in Alagille Syndrome (ALGS)
Figure 33. Global Odevixibat Market: Alagille Syndrome (ALGS) (2021-2026) & (Units)
Figure 34. Odevixibat Consumed in Cholestatic Pruritus in Children and Adults
Figure 35. Global Odevixibat Market: Cholestatic Pruritus in Children and Adults (2021-2026) & (Units)
Figure 36. Odevixibat Consumed in Biliary Atresia & Other Rare Cholestatic Liver Diseases ??????Biliary Atresia????? ??????Odevixibat?????????? ??????Odevixibat??????????
Figure 37. Global Odevixibat Market: Biliary Atresia & Other Rare Cholestatic Liver Diseases ??????Biliary Atresia????? ??????Odevixibat?????????? ??????Odevixibat?????????? (2021-2026) & (Units)
Figure 38. Odevixibat Consumed in Others
Figure 39. Global Odevixibat Market: Others (2021-2026) & (Units)
Figure 40. Global Odevixibat Sale Market Share by Application (2025)
Figure 41. Global Odevixibat Revenue Market Share by Application in 2025
Figure 42. Odevixibat Sales by Company in 2025 (Units)
Figure 43. Global Odevixibat Sales Market Share by Company in 2025
Figure 44. Odevixibat Revenue by Company in 2025 ($ millions)
Figure 45. Global Odevixibat Revenue Market Share by Company in 2025
Figure 46. Global Odevixibat Sales Market Share by Geographic Region (2021-2026)
Figure 47. Global Odevixibat Revenue Market Share by Geographic Region in 2025
Figure 48. Americas Odevixibat Sales 2021-2026 (Units)
Figure 49. Americas Odevixibat Revenue 2021-2026 ($ millions)
Figure 50. APAC Odevixibat Sales 2021-2026 (Units)
Figure 51. APAC Odevixibat Revenue 2021-2026 ($ millions)
Figure 52. Europe Odevixibat Sales 2021-2026 (Units)
Figure 53. Europe Odevixibat Revenue 2021-2026 ($ millions)
Figure 54. Middle East & Africa Odevixibat Sales 2021-2026 (Units)
Figure 55. Middle East & Africa Odevixibat Revenue 2021-2026 ($ millions)
Figure 56. Americas Odevixibat Sales Market Share by Country in 2025
Figure 57. Americas Odevixibat Revenue Market Share by Country (2021-2026)
Figure 58. Americas Odevixibat Sales Market Share by Type (2021-2026)
Figure 59. Americas Odevixibat Sales Market Share by Application (2021-2026)
Figure 60. United States Odevixibat Revenue Growth 2021-2026 ($ millions)
Figure 61. Canada Odevixibat Revenue Growth 2021-2026 ($ millions)
Figure 62. Mexico Odevixibat Revenue Growth 2021-2026 ($ millions)
Figure 63. Brazil Odevixibat Revenue Growth 2021-2026 ($ millions)
Figure 64. APAC Odevixibat Sales Market Share by Region in 2025
Figure 65. APAC Odevixibat Revenue Market Share by Region (2021-2026)
Figure 66. APAC Odevixibat Sales Market Share by Type (2021-2026)
Figure 67. APAC Odevixibat Sales Market Share by Application (2021-2026)
Figure 68. China Odevixibat Revenue Growth 2021-2026 ($ millions)
Figure 69. Japan Odevixibat Revenue Growth 2021-2026 ($ millions)
Figure 70. South Korea Odevixibat Revenue Growth 2021-2026 ($ millions)
Figure 71. Southeast Asia Odevixibat Revenue Growth 2021-2026 ($ millions)
Figure 72. India Odevixibat Revenue Growth 2021-2026 ($ millions)
Figure 73. Australia Odevixibat Revenue Growth 2021-2026 ($ millions)
Figure 74. China Taiwan Odevixibat Revenue Growth 2021-2026 ($ millions)
Figure 75. Europe Odevixibat Sales Market Share by Country in 2025
Figure 76. Europe Odevixibat Revenue Market Share by Country (2021-2026)
Figure 77. Europe Odevixibat Sales Market Share by Type (2021-2026)
Figure 78. Europe Odevixibat Sales Market Share by Application (2021-2026)
Figure 79. Germany Odevixibat Revenue Growth 2021-2026 ($ millions)
Figure 80. France Odevixibat Revenue Growth 2021-2026 ($ millions)
Figure 81. UK Odevixibat Revenue Growth 2021-2026 ($ millions)
Figure 82. Italy Odevixibat Revenue Growth 2021-2026 ($ millions)
Figure 83. Russia Odevixibat Revenue Growth 2021-2026 ($ millions)
Figure 84. Middle East & Africa Odevixibat Sales Market Share by Country (2021-2026)
Figure 85. Middle East & Africa Odevixibat Sales Market Share by Type (2021-2026)
Figure 86. Middle East & Africa Odevixibat Sales Market Share by Application (2021-2026)
Figure 87. Egypt Odevixibat Revenue Growth 2021-2026 ($ millions)
Figure 88. South Africa Odevixibat Revenue Growth 2021-2026 ($ millions)
Figure 89. Israel Odevixibat Revenue Growth 2021-2026 ($ millions)
Figure 90. Turkey Odevixibat Revenue Growth 2021-2026 ($ millions)
Figure 91. GCC Countries Odevixibat Revenue Growth 2021-2026 ($ millions)
Figure 92. Manufacturing Cost Structure Analysis of Odevixibat in 2026
Figure 93. Manufacturing Process Analysis of Odevixibat
Figure 94. Industry Chain Structure of Odevixibat
Figure 95. Channels of Distribution
Figure 96. Global Odevixibat Sales Market Forecast by Region (2027-2032)
Figure 97. Global Odevixibat Revenue Market Share Forecast by Region (2027-2032)
Figure 98. Global Odevixibat Sales Market Share Forecast by Type (2027-2032)
Figure 99. Global Odevixibat Revenue Market Share Forecast by Type (2027-2032)
Figure 100. Global Odevixibat Sales Market Share Forecast by Application (2027-2032)
Figure 101. Global Odevixibat Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Odevixibat
Figure 2. Odevixibat Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Odevixibat Sales Growth Rate 2021-2032 (Units)
Figure 7. Global Odevixibat Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Odevixibat Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Odevixibat Sales Market Share by Country/Region (2025)
Figure 10. Odevixibat Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 1.2 mg capsules
Figure 12. Product Picture of 0.6 mg capsules
Figure 13. Product Picture of 200 mcg Granules
Figure 14. Product Picture of 600 mcg Granules
Figure 15. Global Odevixibat Sales Market Share by Type in 2026
Figure 16. Global Odevixibat Revenue Market Share by Type (2021-2026)
Figure 17. Product Picture of Combination of Odevixibat and Bile Acid Sequestrants
Figure 18. Product Picture of Combination of Odevixibat and Hepatoprotective Agents
Figure 19. Global Odevixibat Sales Market Share by Combination Therapy in 2026
Figure 20. Global Odevixibat Revenue Market Share by Combination Therapy (2021-2026)
Figure 21. Product Picture of Hospital
Figure 22. Product Picture of Retail
Figure 23. Product Picture of Online
Figure 24. Global Odevixibat Sales Market Share by Sales Channels in 2026
Figure 25. Global Odevixibat Revenue Market Share by Sales Channels (2021-2026)
Figure 26. Product Picture of Originator
Figure 27. Product Picture of Generic
Figure 28. Global Odevixibat Sales Market Share by Production Technology in 2026
Figure 29. Global Odevixibat Revenue Market Share by Production Technology (2021-2026)
Figure 30. Odevixibat Consumed in Progressive Familial Intrahepatic Cholestasis (PFIC)
Figure 31. Global Odevixibat Market: Progressive Familial Intrahepatic Cholestasis (PFIC) (2021-2026) & (Units)
Figure 32. Odevixibat Consumed in Alagille Syndrome (ALGS)
Figure 33. Global Odevixibat Market: Alagille Syndrome (ALGS) (2021-2026) & (Units)
Figure 34. Odevixibat Consumed in Cholestatic Pruritus in Children and Adults
Figure 35. Global Odevixibat Market: Cholestatic Pruritus in Children and Adults (2021-2026) & (Units)
Figure 36. Odevixibat Consumed in Biliary Atresia & Other Rare Cholestatic Liver Diseases ??????Biliary Atresia????? ??????Odevixibat?????????? ??????Odevixibat??????????
Figure 37. Global Odevixibat Market: Biliary Atresia & Other Rare Cholestatic Liver Diseases ??????Biliary Atresia????? ??????Odevixibat?????????? ??????Odevixibat?????????? (2021-2026) & (Units)
Figure 38. Odevixibat Consumed in Others
Figure 39. Global Odevixibat Market: Others (2021-2026) & (Units)
Figure 40. Global Odevixibat Sale Market Share by Application (2025)
Figure 41. Global Odevixibat Revenue Market Share by Application in 2025
Figure 42. Odevixibat Sales by Company in 2025 (Units)
Figure 43. Global Odevixibat Sales Market Share by Company in 2025
Figure 44. Odevixibat Revenue by Company in 2025 ($ millions)
Figure 45. Global Odevixibat Revenue Market Share by Company in 2025
Figure 46. Global Odevixibat Sales Market Share by Geographic Region (2021-2026)
Figure 47. Global Odevixibat Revenue Market Share by Geographic Region in 2025
Figure 48. Americas Odevixibat Sales 2021-2026 (Units)
Figure 49. Americas Odevixibat Revenue 2021-2026 ($ millions)
Figure 50. APAC Odevixibat Sales 2021-2026 (Units)
Figure 51. APAC Odevixibat Revenue 2021-2026 ($ millions)
Figure 52. Europe Odevixibat Sales 2021-2026 (Units)
Figure 53. Europe Odevixibat Revenue 2021-2026 ($ millions)
Figure 54. Middle East & Africa Odevixibat Sales 2021-2026 (Units)
Figure 55. Middle East & Africa Odevixibat Revenue 2021-2026 ($ millions)
Figure 56. Americas Odevixibat Sales Market Share by Country in 2025
Figure 57. Americas Odevixibat Revenue Market Share by Country (2021-2026)
Figure 58. Americas Odevixibat Sales Market Share by Type (2021-2026)
Figure 59. Americas Odevixibat Sales Market Share by Application (2021-2026)
Figure 60. United States Odevixibat Revenue Growth 2021-2026 ($ millions)
Figure 61. Canada Odevixibat Revenue Growth 2021-2026 ($ millions)
Figure 62. Mexico Odevixibat Revenue Growth 2021-2026 ($ millions)
Figure 63. Brazil Odevixibat Revenue Growth 2021-2026 ($ millions)
Figure 64. APAC Odevixibat Sales Market Share by Region in 2025
Figure 65. APAC Odevixibat Revenue Market Share by Region (2021-2026)
Figure 66. APAC Odevixibat Sales Market Share by Type (2021-2026)
Figure 67. APAC Odevixibat Sales Market Share by Application (2021-2026)
Figure 68. China Odevixibat Revenue Growth 2021-2026 ($ millions)
Figure 69. Japan Odevixibat Revenue Growth 2021-2026 ($ millions)
Figure 70. South Korea Odevixibat Revenue Growth 2021-2026 ($ millions)
Figure 71. Southeast Asia Odevixibat Revenue Growth 2021-2026 ($ millions)
Figure 72. India Odevixibat Revenue Growth 2021-2026 ($ millions)
Figure 73. Australia Odevixibat Revenue Growth 2021-2026 ($ millions)
Figure 74. China Taiwan Odevixibat Revenue Growth 2021-2026 ($ millions)
Figure 75. Europe Odevixibat Sales Market Share by Country in 2025
Figure 76. Europe Odevixibat Revenue Market Share by Country (2021-2026)
Figure 77. Europe Odevixibat Sales Market Share by Type (2021-2026)
Figure 78. Europe Odevixibat Sales Market Share by Application (2021-2026)
Figure 79. Germany Odevixibat Revenue Growth 2021-2026 ($ millions)
Figure 80. France Odevixibat Revenue Growth 2021-2026 ($ millions)
Figure 81. UK Odevixibat Revenue Growth 2021-2026 ($ millions)
Figure 82. Italy Odevixibat Revenue Growth 2021-2026 ($ millions)
Figure 83. Russia Odevixibat Revenue Growth 2021-2026 ($ millions)
Figure 84. Middle East & Africa Odevixibat Sales Market Share by Country (2021-2026)
Figure 85. Middle East & Africa Odevixibat Sales Market Share by Type (2021-2026)
Figure 86. Middle East & Africa Odevixibat Sales Market Share by Application (2021-2026)
Figure 87. Egypt Odevixibat Revenue Growth 2021-2026 ($ millions)
Figure 88. South Africa Odevixibat Revenue Growth 2021-2026 ($ millions)
Figure 89. Israel Odevixibat Revenue Growth 2021-2026 ($ millions)
Figure 90. Turkey Odevixibat Revenue Growth 2021-2026 ($ millions)
Figure 91. GCC Countries Odevixibat Revenue Growth 2021-2026 ($ millions)
Figure 92. Manufacturing Cost Structure Analysis of Odevixibat in 2026
Figure 93. Manufacturing Process Analysis of Odevixibat
Figure 94. Industry Chain Structure of Odevixibat
Figure 95. Channels of Distribution
Figure 96. Global Odevixibat Sales Market Forecast by Region (2027-2032)
Figure 97. Global Odevixibat Revenue Market Share Forecast by Region (2027-2032)
Figure 98. Global Odevixibat Sales Market Share Forecast by Type (2027-2032)
Figure 99. Global Odevixibat Revenue Market Share Forecast by Type (2027-2032)
Figure 100. Global Odevixibat Sales Market Share Forecast by Application (2027-2032)
Figure 101. Global Odevixibat Revenue Market Share Forecast by Application (2027-2032)
